GLP-1 receptor agonists have transformed weight management and type 2 diabetes treatment. Whether you're just starting or already on your journey, understanding how these medications work helps you get the most from them. This guide covers the major GLP-1 medications, their mechanisms, dosing schedules, and practical tips for success.
What Are GLP-1 Receptor Agonists?
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in the gut after eating. It signals your brain that you're full, slows stomach emptying, and helps regulate blood sugar by stimulating insulin release when glucose is high. GLP-1 receptor agonists are synthetic versions of this hormone that last much longer in your body — the natural hormone is broken down within minutes, while medications can last a full week.
By mimicking and amplifying your body's natural GLP-1 response, these medications help you feel full sooner, stay satisfied longer, and experience fewer cravings. This is why they're so effective for weight loss — they address the biological drivers of appetite rather than relying on willpower alone.
The Major GLP-1 Medications
Semaglutide (Ozempic & Wegovy)
Ozempic was the first once-weekly GLP-1 to gain widespread use, approved for type 2 diabetes in 2017. Wegovy contains the same active ingredient (semaglutide) but is approved for chronic weight management at a higher maximum dose (2.4 mg vs. 2.0 mg). Both are injectable, delivered via a pre-filled pen, and taken once weekly.
Clinical trials showed semaglutide can produce up to 15% body weight loss over 68 weeks — a breakthrough compared to older weight-loss medications that typically achieved 5–10%.
Tirzepatide (Mounjaro & Zepbound)
Mounjaro and Zepbound contain tirzepatide, a newer medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors — a "dual agonist" approach. This dual action produces even greater weight loss, with trials showing up to 22.5% body weight loss over 72 weeks.
Mounjaro is approved for type 2 diabetes; Zepbound is approved for weight management. Both are once-weekly injections with a similar titration schedule to semaglutide.
Other GLP-1 Medications
- Rybelsus — The only oral GLP-1 (semaglutide tablet), taken daily on an empty stomach. Lower efficacy than injectable forms but avoids needles.
- Saxenda (liraglutide) — A daily injection approved for weight management. Older generation, lower efficacy (~8% weight loss), but some patients prefer daily dosing.
- Victoza — Same drug as Saxenda (liraglutide) but approved for type 2 diabetes at lower doses.
How GLP-1 Medications Work
GLP-1 receptor agonists work through three primary mechanisms:
- Appetite suppression: They act on receptors in the brain's appetite center (hypothalamus), reducing hunger and increasing feelings of fullness. You eat less without feeling deprived.
- Delayed gastric emptying: They slow the rate at which food leaves your stomach, prolonging fullness after meals. This is also why nausea is a common side effect.
- Blood sugar regulation: They stimulate insulin release when blood sugar is high and suppress glucagon, helping maintain stable glucose levels.
Typical Dosing Schedules
GLP-1 medications use a gradual titration (dose escalation) schedule to minimize side effects. Your body needs time to adjust to each dose level before increasing. Here's a typical semaglutide (Wegovy) schedule:
- Month 1: 0.25 mg once weekly (starting dose)
- Month 2: 0.5 mg once weekly
- Month 3: 1.0 mg once weekly
- Month 4: 1.7 mg once weekly
- Month 5+: 2.4 mg once weekly (maintenance)
Tirzepatide follows a similar pattern, starting at 2.5 mg and increasing to 5, 7.5, 10, 12.5, and 15 mg over several months. Your doctor will adjust based on your tolerance and results — some patients stay at lower doses if they're responding well.
What to Expect: Timeline of Results
- Weeks 1–2: Appetite changes are usually the first sign. Many patients report feeling full faster and having fewer cravings.
- Weeks 2–4: Initial weight loss begins, often 2–5 lbs. Side effects (nausea, fatigue) are most common during this period.
- Months 2–3: Weight loss accelerates as you reach therapeutic doses. Most patients lose 5–10% of body weight by month 3.
- Months 4–6: Rate of loss may slow as your body adjusts. This is normal — consistency matters more than speed.
- Months 6+: Transition to maintenance. Some patients continue losing; others stabilize. Regular tracking helps you and your doctor assess whether to adjust the dose.
Maximizing Your Results
GLP-1 medications are powerful, but they work best as part of a comprehensive approach:
- Prioritize protein: Aim for 0.8–1.0 grams of protein per pound of lean body mass to preserve muscle during weight loss. Without adequate protein, up to 40% of weight lost can be muscle.
- Strength train 2–3x per week: Resistance training signals your body to keep muscle while losing fat. This is critical — GLP-1s reduce appetite for all food, including protein.
- Stay hydrated: GLP-1s increase fullness, which can reduce fluid intake. Aim for 64+ oz of water daily.
- Track everything: Logging your doses, side effects, meals, and weight gives you and your doctor a complete picture to optimize your treatment.
- Be patient with titration: Side effects usually subside as your body adjusts. Don't rush dose increases if you're struggling.
OptimizeGLP was built specifically for GLP-1 patients — it tracks your injection schedule, logs side effects, calculates your protein targets, and visualizes your progress so you can see exactly how far you've come.
Important Safety Considerations
GLP-1 medications are generally safe but aren't suitable for everyone. You should not take GLP-1 medications if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Contact your doctor immediately if you experience severe abdominal pain (possible pancreatitis), persistent vomiting, or signs of an allergic reaction.
Always consult your prescribing physician before starting, stopping, or adjusting any medication. This guide is educational and not a substitute for professional medical advice.